BioSpace News Archive

Mana Capital Acquisition Corp. announced that its registration statement on Form S-4, relating to the previously announced business combination between Mana Capital and Cardio Diagnostics, Inc., a pioneering precision cardiovascular testing company, has been declared effective by the U.S. Securities and Exchange Commission.

Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients has completed development of a six-hour blood test to predict organ transplant rejection - PlexAPR™.

HUTCHMED Limited announces that it has initiated a Phase II/III trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia in China.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis who received 12 weeks of combination induction therapy with guselkumab and golimumab.

Merck, known as MSD outside of the United States and Canada, announced positive top-line results from the pivotal Phase 3 STELLAR trial evaluating the safety and efficacy of sotatercept, an investigational activin receptor type IIA-Fc fusion protein being evaluated as an add-on to stable background therapy for the treatment of pulmonary arterial hypertension .

Zynerba Pharmaceuticals, Inc. today announced the presentation of a poster at the 2022 National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit being held October 17-18, 2022 in Washington, D.C.

Passage Bio, Inc. today announced the appointment of William Chou, M.D. as chief executive officer (CEO) and a member of the board, effective immediately.

Axsome Therapeutics, Inc. is joining the World Health Organization’s (WHO) 2022 World Mental Health Day campaign to make mental health and well-being for all a global priority.

Microbot Medical Inc. (Nasdaq: MBOT) is continuing to expand its global intellectual property portfolio for the LIBERTY ® Robotic System as a patent allowance was issued by the Israeli Patent Office, covering the LIBERTY Robotic System’s roll assembly mechanism.

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 1, 2022 , at 8:00 a.m. CDT to review first quarter 2023 financial results.